January 21, 2026
Spada brings over a decade of specialized trace detection expertise to accelerate the deployment of mass spectrometry technology across global security markets AUSTIN, Texas -- Astrotech Corporation (Nasdaq: ASTC) (the “Company” or “Astrotech”) today announced that its subsidiary, 1st Detect Corporation (“1st Detect”), has appointed industry veteran, David Spada, as Director of Global Sales. This strategic hire [...]
January 20, 2026
HOUSTON -- Sino Biological, Inc. is proud to announce the launch of its innovative SwiftFluo® TR-FRET Kinase Assay Kits, a ready-to-use, high-performance solution designed to accelerate kinase activity detection and high-throughput kinase inhibitor screening. Leveraging advanced Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) technology, these kits deliver exceptional sensitivity, low background, and robust reproducibility. This enables rapid, reliable, [...]
Parse Biosciences and Graph Therapeutics Partner to Build Large Functional Immune Perturbation Atlas
January 20, 2026
Partnership unites AI and single cell technology to map immune dysfunction and improve drug discovery and development outcomes SEATTLE & VIENNA -- Parse Biosciences and Graph Therapeutics (Graph) today announced a strategic partnership to create one of the largest and most comprehensive immune cell perturbation atlases. The collaboration will leverage Graph's lab-in-the-loop platform with Parse's [...]
January 20, 2026
Industrial-ready spectrometer delivers high throughput and low optical distortion HORIBA, a global leader in analytical and measurement technology, announces it has developed the PoliSpectra® 27, a compact, lightweight industrial spectrometer platform designed to support high-volume manufacturing and integration into hyperspectral imaging systems. The PoliSpectra 27 combines high optical throughput with low stray light, enabling precise [...]
Reference standards improve AAV production.
January 20, 2026
Amsbio announces a new range of well characterized Adeno-Associated Virus (AAV) reference standards that enable researchers to significantly improve their AAV production processes. Adeno-associated virus can be engineered to transport DNA of interest to target cells, without any viral genes - making them a highly desirable and safe tool for gene therapy. However, one of the greatest challenges [...]
LabKey Debuts Mining LIMS for Mining & Metallurgical Labs
January 20, 2026
Configurable workflows support high-volume mining lab operations across sites and shifts—without forcing a one-size-fits-all process. As mining organizations modernize lab operations, they need systems that match the way their labs actually work and scale as requirements evolve.” — Michael Gersch, CEO, LabKey SEATTLE, WA, UNITED STATES — LabKey today announced LabKey Mining LIMS, an intuitive [...]
Introducing the Copley Inhaled Dissolution Apparatus IDA
January 20, 2026
Introducing the Copley Inhaled Dissolution Apparatus: a first-of-a-kind commercially available solution for inhaled product dissolution testing. Nottingham, UK: The innovative Inhaled Dissolution Apparatus (IDA) from Copley Scientific introduces discriminating dissolution testing to the commercially available in vitro toolkit for inhaled drug products. Addressing a longstanding and evolving industrial need, it brings new insights into in vivo behaviour, enabling faster [...]
Eurofins and trinamiX launch Mobile Feed Analysis Solution for Equine Nutrition
January 20, 2026
Wageningen, Netherlands, Ludwigshafen, Germany — Eurofins Agro Testing and trinamiX GmbH, announce a jointly developed mobile feed analysis solution for the equine sector that brings best-in-class forage testing directly to stables and pastures across Europe. This empowers stable owners, horse feed producers, equine nutritionists, forage dealers and veterinary professionals to make informed decisions based on [...]
January 20, 2026
Vancouver, BC — Telescope Innovations Corp., (“Telescope” or the “Company”) (CSE: TELI) (OTCQB: TELIF) (FSE: J4U), is a leader in Physical AI, Self-Driving Laboratories, and enabling technology supporting autonomous laboratory infrastructure. The Company is pleased to provide a look at its planned 2026 technology development pipeline, which aligns with its Self-Driving Lab (SDL) architecture for autonomous chemistry R&D. Building on the [...]
January 20, 2026
Abcam has joined an industry-academic partnership led by the Structural Genomics Consortium and Pfizer to advance AI-driven drug discovery through open science, a new public-private partnership with a budget of more than €60 million. Through this collaboration, the Innovative Health Initiative Project LIGAND‑AI will generate large, high-quality protein–ligand datasets to support the development of predictive [...]

